Page last updated: 2024-08-21

thiazolidines and dactolisib

thiazolidines has been researched along with dactolisib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ben-Salha, I; Costa, H; Echeverria, LMC; Freeman, A; Gately, KA; Haider, A; Heavey, S; Jameson, C; Kelly, JD; Kumar, C; Luszczak, S; Pye, H; Ratynska, M; Sathyadevan, VK; Shaw, G; Simpson, BS; Sridhar, A; Stopka-Farooqui, U; Whitaker, HC1

Other Studies

1 other study(ies) available for thiazolidines and dactolisib

ArticleYear
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
    Scientific reports, 2020, 09-01, Volume: 10, Issue:1

    Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; Pyrimidines; Quinolines; RNA, Messenger; Signal Transduction; Thiazolidines; Thiophenes; TOR Serine-Threonine Kinases

2020